It's time for the XXVII #ISG Annual Meeting last battle!!!
✅ Thanks to our special guest Patricia Pautier and to Dario Callegaro and Roberta Sanfilippo for the fascinating debate on the LMS-04 trial.
⁉️ Impressive results but many questions are still pending!!

A new 🌟 TARPSWG achievement: solid data on the largest series of WDLPS #retroperitoneal #sarcoma : after Neoadjuvant RT significantly reduced local recurrence rate Vs surgery alone. #STRASS and #STREXIT data are now corroborated. Great job Mark Fairweather! #SSO2024 #plenary

#ESMOSarcomaAndRareCancers24

Nice discussion to finalize the retroperitoneal #sarcoma (RPS) session. My take: treating RPS is COMPLEX and multidisciplinary care is KEY. No gold standard can be applied for all cases, other than evidence-based individualized care by specialists.

#ESMOSarcomaAndRareCancers24

Roberta Sanfilippo with a great discussion on rare histotypes of retroperitoneal #sarcoma .

#RESURGE has come to 10th edition! EYSAC GEIS Grupo Mexicano de Sarcomas SoMe4Surgery @SoMe4sarcoma

New research: Long-term disease stability with bicalutamide in a man with aggressive angiomyxoma: case report and state of art: Aggressive angiomyxoma (AA) is a rare mesenchymal neoplasm, which is commonly diagnosed in females and located in… frontiersin.org/articles/10.33… #oncology

Thanks to Frontiers - Oncology for publishing today our report of a very rare disease successfully managed with a well known drug.

Istituto Tumori Roberta Sanfilippo Sandro Pasquali Paolo G Casali

Localized primary High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of R Trial From Italian Sarcoma Group GEIS , French (FSG), and Polish Sarcoma Groups (PSG): trabectedin is not inferior to AI when neoadjuvant chemotherapy is a consideration. ascopubs.org/doi/10.1200/JC…

Rick Haas giving Nina Axelrod #CTOS2023 on radiation therapy for #sarcoma patients. MRCLS #liposarcoma registry OncoAlert

Well deserved Rick. Congratulations!

MANTRA
Ph 3 MDM2-p53 antagonist milademetan v TRAB
For unresectable/ met #ddLPS By Roberta Sanfilippo
#sarcoma at #CTOS2023

🔹mPFS 3.6m v 2.2m p 0.53

🤔 Some responses were seen- need work out who is benefitting

🤔 results MANTRA v brigimadlin

#CTOSTweeTOS

TARPSWG dinner in #Dublin #Baileathacliath celebrating 10th anniversary of terrific collaboration, connection, discussion, progress and fun!

TARPSWG 10th yr anniversary. Who could have guessed back then how much we would have been able to achieve? Hundreds of members for multiple countries and 5 continents! And an observational study with thousands of pts in it! CTOS Society of Surgical Oncology European Society of Surgical Oncology (ESSO) EORTC

Starting Ultra-rare sarcoma working group meeting with Silvia Stacchiotti describing needs in the field
William Tap Liz Connolly Anna Maria Frezza #ctos2023 #CTOSTweeTOS CTOS

On this episode of #SARCtalk , Roberta Sanfilippo shares her insights on mentorship, collaboration, and #clinicaltrials in Europe. #sarcoma #SARCtrials #liposarcoma #leiomyosarcoma

Take a listen: open.spotify.com/episode/37xedF…

Don’t miss Roberta Sanfilippo discussing new advances in #sarcoma SARC :

youtu.be/Y9VtwWhixbo?si…

Istituto Tumori OncoAlert Sylvester Comprehensive Cancer Center

Il leiomiosarcoma uterino a basso grado esiste, e risponde alla terapia ormonale tinyurl.com/ywdtxr9d

Low grade uterine Leiomyosarcoma does exist !
aacrjournals.org/clincancerres/…
Paolo Dei Tos
Paolo G Casali
Marisa R Nucci
Ray-Coquard Isabelle
Jon Trent, MD, PhD
Croce Sabrina
Clinical Cancer Research
ChiaraFabbroni
CTOS
ESGO
LeioMyoSarcoma

CTOS program is out! Looking forward to seeing colleagues and discussing new data and efforts to improve sarcoma care in November. #CTOS2023 #sarcoma

ctos2023.eventscribe.net